title: Microangiopathic haemolysis associated with occult carcinoma.
abstract: Microangiopathic haemolytic anaemia (MAHA) is a well recognized complication of disseminated carcinoma and its treatment. It is however, rarely seen with localized carcinoma. The case presented here is a previously unreported association of a patient, who having been successfully treated for MAHA, was found to have occult breast carcinoma on a routine screening mammogram six months after the haemolytic episode.
authors.affiliation: Department of Haematology, Royal London Hospital, Whitechapel.
authors.forename: P W
authors.initials: PW
authors.lastname: Collins
authors.forename: L
authors.initials: L
authors.lastname: Jones
authors.forename: C
authors.initials: C
authors.lastname: Pocock
authors.forename: A C
authors.initials: AC
authors.lastname: Newland
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000150:complications* / Q000000981:diagnostic imaging; D000743:Anemia, Hemolytic / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D001943:Breast Neoplasms / Q000097:blood / Q000150:complications* / Q000000981:diagnostic imaging; D003907:Dexamethasone / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000097:blood / Q000150:complications*; D010951:Plasma Exchange; D011014:Pneumonia / Q000150:complications; D011859:Radiography; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D011464:Epoprostenol